After silencing VDAC1 expression in cancer cells for an extended period of 10–15 days, significant reductions in glioblastoma cancer stem cell (GSC) markers were observed, accompanied by morphological changes indicative of differentiation into more mature, normal-like cells [74,94]. This evidence concerns the gene VDAC1 and glioblastoma.